Dong M. Shin is an internationally acclaimed cancer researcher who interests include malignant pleural mesothelioma.
- Serves as executive vice-chair of the institute’s Hematology and Oncology departments.
- Research focuses on development of cancer biomarkers, molecular-targeted therapies, and nanotechnologies for detecting circulating tumor cells and for precision-delivery of cancer drugs.
- Name attached to some 200 peer-reviewed publications, more than 40 invited articles and 260 abstracts, books, book chapters and monographs on the biology and treatment of head and neck cancer, and other malignancies.
- Editorial board member of the Journal of Clinical Oncology, Clinical Cancer Research, American Journal of Clinical Oncology, and Molecular Cancer Therapy.
- Teaches at Emory School of Medicine; holds Frances Kelly Blomeyer Chair in Cancer Research.
- Appointments includeco-chair of Cancer Prevention Committee, Eastern Cooperative Oncology Group, Chemoprevention Committee member, Radiation Therapy Oncology Group, Head and Neck Cancer Committee member, Eastern Cooperative Oncology Group, and Physician Data Query External Advisory Board member, National Cancer Institute.
- Fellow of American College of Physicians.
- Member of the American Society of Clinical Oncology, American Head and Neck Society, and American Association for Cancer Research.
- Named a “Best Doctor in America” (2003-04) and a “Top Doctor in Oncology in Atlanta” (2005).
- M.D. degree from Yonsei University College of Medicine, Seoul, South Korea.